Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01678027 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Dec 2023 to Dec 2035v9
  2. 2 versions Re-verified since Oct 26, 2020, no change to tracked fieldsv7-v8
  3. Primary completion date: Dec 2017 to Dec 2018v6
  4. Enrollment target: 1837 to 1838v5
  5. Enrollment target: estimated 1810 to confirmed 1837v4 Show 5 more changesShow less
    • Primary completion date changed from estimate of Feb 2018 to Dec 2017
    • Study completion date: Feb 2018 to Dec 2023
    • Secondary endpoints revised (4)
    • Study description expanded, about 102 words
    • Site details revised
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Feb 2018
    • Secondary endpoints: 2 to 4
    • Site details revised
    v3
  2. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study evaluate whether treatment of Helicobacter pylori infection reduces the incidence of gastric cancer in subjects with family history of gastric cancer.
Trial Details
NCT Number NCT01678027
Lead Sponsor National Cancer Center, Korea
Conditions
(from sponsor)		 Gastric Cancer, Helicobacter Pylori Infection, Family Members
Related terms Stomach Neoplasms
Enrollment 1,838 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov